Matching slides 110,355
Current window 44,521-44,550
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all

Component

44,521-44,550 of 110,355

filter-aware
37
The slide uses red underlining to emphasize the 'FDA Determined Cause' for both recalls.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
38
Uses a before-after comparison to frame the company's previous disclosures as insufficient.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
39
Uses a combination of expert testimony and regulatory documentation to cast doubt on the safety profile of the procedure.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
40
Uses a table to present qualitative evidence (quotes) to undermine a company's narrative.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
41
Uses a table format to present qualitative evidence from interviews to contradict company claims.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
42
The slide uses a 'villain' framing technique to discredit the company's marketing claims.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
43
Uses a direct quote from a Tegus interview to undermine the company's value proposition.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
44
The slide uses a table format to present qualitative evidence (interviews) to support a bearish thesis.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
45
Uses red underlining to highlight specific risk-related clauses in legal text.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
46
Uses a grid layout to present four distinct supplier profiles as evidence of operational risk.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
48
Uses side-by-side comparison of two Procept investor presentations to expose a shift in narrative that the activist deems unrealistic.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller Loop · Mece Breakdown1 hit
49
Uses AUA clinical guidelines to frame the company's addressable market as smaller than claimed.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller Loop · Mece Breakdown1 hit
50
Uses expert interviews to contradict company TAM claims.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller Loop · Mece Breakdown1 hit
51
The slide uses a red box to highlight the discrepancy between the company's claim and the academic average.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller Loop · Mece Breakdown1 hit
52
The slide uses a combination of AHRQ NIS data and Dowling (CMS) data to triangulate procedure volumes.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller Loop · Mece Breakdown1 hit
53
Includes a testimonial/interview excerpt to support the claim of misapplied diagnosis codes.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller Loop · Mece Breakdown1 hit
54
Includes a red box highlight on the 52% penetration metric and the actual handpiece units sold row, with an arrow connecting them.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller Loop · Mece Breakdown1 hit
55
Uses a table format to present primary source interview quotes as evidence against market growth assumptions.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
56
Includes a table comparing disclosed utilization vs. calculated utilization, and a table from AUA 2023 Census on procedure volume.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
57
The slide uses direct quotes from industry participants to undermine the growth thesis of the target company.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
58
The slide uses a table to demonstrate that procedure growth (excluding Rezum) is lower than the growth of the target demographic (men 65+ and 65-75).PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
59
Includes a red-boxed excerpt from official CMS documentation highlighting specific clinical criteria.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
60
The slide uses a comparison table format to list specific patient-related inhibitors to Aquablation adoption.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
61
The slide uses a red-and-white table format to present qualitative arguments against the adoption of a specific medical technology.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
63
Includes a histogram of prostate sizes and a supporting quote from a urologist.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
64
Uses a histogram with red annotations to highlight market segments where the product is less competitive or not indicated.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
65
Includes a chart showing stable intervention rates and a quote from a urologist supporting the shift toward less invasive procedures.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller 1 hit
67
Uses a combination of company-specific highlights, expert testimonials, and direct quotes to undermine the target company's market position.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller Loop · Voice Of Customer1 hit
68
Includes a quote from a Urodoc on SeekingAlpha and a summary of a cost-effectiveness study.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller Loop · Voice Of Customer1 hit
69
Includes a direct quote from a urologist validating the superiority of laser-based HoLEP over waterjet-based ablation.PROCEPT BioRobotics Corporation (PRCT) · Spruce Point Capital Management
Activist deck Short seller Loop · Voice Of Customer1 hit